Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created LabeledIn, a detailed list of drug uses, showing the importance of human input in making such lists.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Female hair loss linked to metabolic syndrome, not in males.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Finasteride effectively treats hair loss in transgender men with few side effects.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Men can report their own balding patterns well enough for large health studies.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Higher aldosterone levels link to hair loss and high blood pressure.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.